Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{e071d0b3615b4e4d877a19c16a12e8fd,

title = "Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02",

author = "Minesh Mehta",

note = "Journal of Neuro-Oncology (2018) 136(1):79-86",

year = "2018",

month = jan,

day = "1",

language = "American English",

volume = "136",

journal = "Journal of neuro-oncology",

}